Search Results1-20 of  20

  • TOGUCHI HAJIME ID: 9000002861565

    武田薬品製剤研究所 (1992 from CiNii)

    Articles in CiNii:3

    • S-2 これからの薬と DDS (1991)
    • A-36 分割錠剤の設計と評価 (1992)
    • 製剤技術の展望 : 21世紀へ向けて (1989)
  • TOGUCHI HAJIME ID: 9000005181383

    Central Research Division, Takeda Chemical Industries, Ltd., (1986 from CiNii)

    Articles in CiNii:1

    • Evaluation of Sustained-Release Capsules of Molsidomine (SIN-10) in Dogs and Monkeys (1986)
  • TOGUCHI HAJIME ID: 9000005213532

    Central Research Division, Takeda Chemical Industries, Ltd. (1984 from CiNii)

    Articles in CiNii:2

    • RADIOIMMUNOASSAY OF THYROTROPIN-RELEASING HORMONE (TRH) IN RAT, DOG, AND HUMAN BLOOD (1983)
    • ABSORPTION OF THYROTROPIN-RELEASING HORMONE AFTER ORAL ADMINISTRATION OF TRH TARTRATE MONOHYDRATE IN THE RAT, DOG AND HUMAN (1984)
  • TOGUCHI HAJIME ID: 9000253212554

    Articles in CiNii:1

    • Radioimmunoassay of thyrotropin-releasing hormone (TRH) in rat, dog, and human blood. (1983)
  • TOGUCHI HAJIME ID: 9000253212781

    Articles in CiNii:1

    • Absorption of thyrotropin-releasing hormone after oral administration of TRH tartrate monohydrate in the rat, dog and human. (1984)
  • TOGUCHI HAJIME ID: 9000254226730

    Articles in CiNii:1

    • Evaluation of sustained-release capsules of molsidomine (SIN-10) in dogs and monkeys. (1986)
  • TOGUCHI HAJIME ID: 9000254228988

    Japan and Pharmaceutical Development Laboratories, Takeda Chemical Industries (1988 from CiNii)

    Articles in CiNii:1

    • Quantitative analysis of hemolytic action of lysophosphatidylcholines in vitro: Effect of acyl chain structure. (1988)
  • TOGUCHI Hajime ID: 9000005185552

    Pharmaceutics Research Laboratories, Research and Development Division, Takeda Chemical Industries, Ltd. (1991 from CiNii)

    Articles in CiNii:6

    • 乳糖粉砕物の結晶水の挙動に関する研究 (1975)
    • Gastro-Intestinal Absorption of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate from Different Dosage Forms in Rats and Dogs (1990)
    • Effects of the Physicochemical Properties of the Emulsion Formulation of the Bioavailability of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in Rats (1990)
  • TOGUCHI Hajime ID: 9000006249406

    Formulation Development 1, Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd. (2006 from CiNii)

    Articles in CiNii:1

    • Optimization of Suppository Preparation Containing Sodium Laurate and Taurine That Can Safely Improve Rectal Absorption of Rebamipide (2006)
  • TOGUCHI Hajime ID: 9000020233595

    Articles in CiNii:1

    • Pharmacokinetic Alteration in Rats of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with a Monoclonal Antibody against rIL-2. (1994)
  • TOGUCHI Hajime ID: 9000020315819

    Articles in CiNii:1

    • Enhancement of the Anti-tumor Activity of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with an F(ab')2 Fragment of Murine Monoclonal Antibody against rIL-2. (1994)
  • TOGUCHI Hajime ID: 9000254232437

    Articles in CiNii:1

    • Effects of physiological factors on the bioavailability of ethyl 2-chloro-3-(4-(2-methyl-2-phenyl-propyloxy) phenyl) propionate in an emulsion in rats. (1990)
  • TOGUCHI Hajime ID: 9000254232441

    Articles in CiNii:1

    • Effects of the physicochemical properties of the emulsion formulation on the bioavailability of ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropyloxy)phenyl) propionate in rats. (1990)
  • TOGUCHI Hajime ID: 9000254232444

    Articles in CiNii:1

    • Gastro-intestinal absorption of ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropyloxy)phenyl) propionate from different dosage forms in rats and dogs. (1990)
  • TOGUCHI Hajime ID: 9000392642041

    Articles in CiNii:1

    • Once-a-Month Injectable Microcapsules of Leuprorelin Acetate (1991)
  • Toguchi Hajime ID: 9000002596088

    Pharmaceutical Research Division, Takeda Chemical Industries Ltd. (1996 from CiNii)

    Articles in CiNii:1

    • <Reviews>Practical Examples of DDS (Drug Delivery System) Studies : Dosage-form design for leuprorelin acetate and other drugs (1996)
  • Toguchi Hajime ID: 9000021143080

    Pharmaceutics Research Laboratories, Research & Development Division, Takeda Chemical Industries, Ltd. (1992 from CiNii)

    Articles in CiNii:1

    • Anticancer effects of chemoembolization using microspheres of an angiogenesis inhibitor (TNP-470) in rabbits bearing VX-2 carcinoma. (1992)
  • Toguchi Hajime ID: 9000021151928

    DDS Research Laboratories, Pharmaceutical Research Division, Takeda Chemical Industries, Ltd. (1993 from CiNii)

    Articles in CiNii:1

    • Sustained release preparation of erythropoietin using sodium hyaluronate. (1993)
  • Toguchi Hajime ID: 9000258575465

    Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., (2009 from CiNii)

    Articles in CiNii:1

    • THE ESTABLISHMENT OF HUMAN ABSORPTION PREDICTION SYSTEM BY MINI-USSING CHAMBER USING HUMAN INTESTINAL TISSUES (2009)
  • Toguchi Hajime ID: 9000283796796

    Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd. (2004 from CiNii)

    Articles in CiNii:1

    • NOVEL ORAL ABSORPTION IMPROVING SYSTEM UTILIZING POLYAMINES (2004)
Page Top